Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
Fuji
Daiichi Sankyo
Medtronic
Covington
Mallinckrodt
Argus Health
Boehringer Ingelheim

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TORSEMIDE

« Back to Dashboard

Clinical Trials for Torsemide

Trial ID Title Status Sponsor Phase Summary
NCT00334386 Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. Completed Ferrer Internacional S.A. Phase 4 Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.
NCT00602303 Bioequivalency Study of Torsemide Tablets Under Fasting Conditions Completed Roxane Laboratories N/A The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00602615 Bioequivalency Study of Torsemide Tablets Under Fed Conditions Completed Roxane Laboratories N/A The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00653549 Bioavailability Study of Torsemide Tablets Under Fasting Conditions Completed Anapharm Phase 1 To compare the single-dose bioavailability of Torsemide tablets with Demadex
NCT00653549 Bioavailability Study of Torsemide Tablets Under Fasting Conditions Completed Par Pharmaceutical, Inc. Phase 1 To compare the single-dose bioavailability of Torsemide tablets with Demadex
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Torsemide

Condition Name

Condition Name for Torsemide
Intervention Trials
Heart Failure 3
Edema 2
Congestive Heart Failure 2
Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Torsemide
Intervention Trials
Heart Failure 7
Hypertension 3
Atrial Fibrillation 1
Body Weight Changes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Torsemide

Trials by Country

Trials by Country for Torsemide
Location Trials
United States 6
India 3
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Torsemide
Location Trials
Missouri 2
Texas 1
North Carolina 1
Massachusetts 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Torsemide

Clinical Trial Phase

Clinical Trial Phase for Torsemide
Clinical Trial Phase Trials
Phase 4 5
Phase 2 1
Phase 1 6
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Torsemide
Clinical Trial Phase Trials
Not yet recruiting 6
Completed 6
Recruiting 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Torsemide

Sponsor Name

Sponsor Name for Torsemide
Sponsor Trials
Sarfez Pharmaceuticals, Inc. 3
Par Pharmaceutical, Inc. 2
Anapharm 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Torsemide
Sponsor Trials
Industry 13
Other 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
McKesson
Julphar
Boehringer Ingelheim
Harvard Business School
Chubb
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.